Publications by authors named "Anna Vaque"

Claim this Profile
A
Adverse Reactions Following First-Dose Administration of Co-Crystal of Tramadol-Celecoxib Versus Tramadol Alone for Moderate-To-Severe Acute Pain.
Adelaida Morte, Mariano Sust, Anna Vaqué, Jesús Cebrecos, José María Giménez-Arnau

Pain Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E-52862-A selective sigma-1 receptor antagonist, in peripheral neuropathic pain: Two randomized, double-blind, phase 2 studies in patients with chronic postsurgical pain and painful diabetic neuropathy.
Rafael Gálvez, Victor Mayoral, Jesús Cebrecos, Francisco J Medel, Adelaida Morte

Eur J Pain· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Co-Crystal of Tramadol-Celecoxib (CTC) in Patients with Acute Moderate-to-Severe Pain: Pooled Analysis of Three Phase 3 Randomized Trials.
Eugene R Viscusi, Richard Langford, Adelaida Morte, Anna Vaqué, Jesús Cebrecos

Pain Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Celecoxib-tramadol co-crystal in patients with moderate-to-severe pain following bunionectomy with osteotomy: Secondary analyses by baseline pain intensity and use of rescue medication of a phase 3, randomized, double-blind, factorial, active- and placebo-controlled trial.
Eugene R Viscusi, Oscar de Leon-Casasola, Jesús Cebrecos, Adam Jacobs, Adelaida Morte

Pain Pract· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-crystal of Tramadol-Celecoxib Versus Tramadol or Placebo for Acute Moderate-to-Severe Pain After Oral Surgery: Randomized, Double-Blind, Phase 3 Trial (STARDOM1).
Richard Langford, Esther M Pogatzki-Zahn, Adelaida Morte, Mariano Sust, Jesús Cebrecos

Adv Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Bioavailability Study of a Novel Multi-Day Patch Formulation of Rivastigmine (Twice Weekly) with Exelon® Transdermal Patch (Daily)- A Randomized Clinical Trial.
Bjoern Schurad, Cornelius Koch, Barbara Schug, Adelaida Morte, Anna Vaqué

Curr Alzheimer Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Celecoxib-tramadol co-crystal in patients with moderate-to-severe pain following bunionectomy with osteotomy: A phase 3, randomized, double-blind, factorial, active- and placebo-controlled trial.
Eugene R Viscusi, Oscar de Leon-Casasola, Jesús Cebrecos, Adam Jacobs, Adelaida Morte

Pain Pract· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of co-crystal of tramadol-celecoxib (CTC) in acute moderate-to-severe pain after abdominal hysterectomy: A randomized, double-blind, phase 3 trial (STARDOM2).
Richard Langford, Adelaida Morte, Mariano Sust, Jesús Cebrecos, Anna Vaqué

Eur J Pain· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioavailability Study of a Transdermal Patch Formulation of Rivastigmine Compared with Exelon in Healthy Subjects.
Adelaida Morte, Anna Vaqué, Marc Iniesta, Barbara Schug, Cornelius Koch

Eur J Drug Metab Pharmacokinet· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Celecoxib-tramadol co-crystal: A Randomized 4-Way Crossover Comparative Bioavailability Study.
Jesús Cebrecos, James D Carlson, Gregorio Encina, Mounia Lahjou, Artur Sans

Clin Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-crystal of Tramadol-Celecoxib in Patients with Moderate to Severe Acute Post-surgical Oral Pain: A Dose-Finding, Randomised, Double-Blind, Placebo- and Active-Controlled, Multicentre, Phase II Trial.
José López-Cedrún, Sebastián Videla, Miguel Burgueño, Inma Juárez, Samir Aboul-Hosn

Drugs R D· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of multiple doses of co-crystal of tramadol-celecoxib: findings from a four-way randomized open-label phase I clinical trial.
Sebastián Videla, Mounia Lahjou, Anna Vaqué, Mariano Sust, Marisol Escriche

Br J Clin Pharmacol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial.
Jordi Bruna, Sebastián Videla, Andreas A Argyriou, Roser Velasco, Jesús Villoria

Neurotherapeutics· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-dose pharmacokinetics of co-crystal of tramadol-celecoxib: Results of a four-way randomized open-label phase I clinical trial in healthy subjects.
Sebastián Videla, Mounia Lahjou, Anna Vaqué, Mariano Sust, Mercedes Encabo

Br J Clin Pharmacol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability and pharmacokinetics of single and multiple doses of a novel sigma-1 receptor antagonist in three randomized phase I studies.
Montserrat Abadias, Marisol Escriche, Anna Vaqué, Mariano Sust, Gregorio Encina

Br J Clin Pharmacol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suspected cross-hepatotoxicity of flutamide and cyproterone acetate.
Mireia Miquel, Aina Soler, Anna Vaqué, Isabel Ojanguren, Joan Costa

Liver Int· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis